FLASH SPRING SALE: 50% Off Premium Subscription >> FLASH SPRING SALE: 50% Off Premium >>
$4.74
-0.0900 (-1.86%)
At Close: May 01, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $4.40 $5.74 Wednesday, 1st May 2024 VTGN stock ended at $4.74. This is 1.86% less than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 4.24% from a day low at $4.72 to a day high of $4.92.
90 days $3.91 $5.74
52 weeks $1.62 $24.71

Historical VistaGen Therapeutics Inc prices

Date Open High Low Close Volume
Jul 18, 2022 $23.70 $24.30 $23.40 $23.70 45 067
Jul 15, 2022 $27.30 $27.30 $23.10 $23.40 51 773
Jul 14, 2022 $27.00 $28.20 $25.50 $25.80 32 627
Jul 13, 2022 $25.50 $28.20 $25.50 $27.00 28 283
Jul 12, 2022 $27.60 $27.90 $25.80 $26.10 36 237
Jul 11, 2022 $28.50 $29.10 $27.30 $27.90 29 110
Jul 08, 2022 $29.10 $29.70 $27.30 $27.90 63 620
Jul 07, 2022 $27.30 $29.10 $27.30 $28.80 28 723
Jul 06, 2022 $26.70 $30.30 $26.40 $27.30 66 533
Jul 05, 2022 $26.40 $27.30 $24.90 $26.40 34 653
Jul 01, 2022 $26.40 $27.30 $25.80 $26.10 30 117
Jun 30, 2022 $26.70 $27.00 $25.80 $26.40 19 743
Jun 29, 2022 $27.00 $28.80 $26.40 $27.00 60 727
Jun 28, 2022 $29.70 $30.00 $25.80 $27.30 57 923
Jun 27, 2022 $30.00 $30.30 $28.80 $28.80 63 277
Jun 24, 2022 $30.00 $30.90 $27.60 $29.40 101 290
Jun 23, 2022 $32.10 $32.10 $29.10 $31.20 32 460
Jun 22, 2022 $32.40 $33.00 $29.70 $30.60 60 750
Jun 21, 2022 $30.60 $32.10 $30.60 $31.80 42 030
Jun 17, 2022 $28.80 $30.90 $28.50 $29.70 60 853
Jun 16, 2022 $27.30 $28.20 $26.10 $28.20 27 130
Jun 15, 2022 $27.30 $28.50 $26.70 $28.20 36 697
Jun 14, 2022 $29.10 $29.40 $27.00 $27.00 34 147
Jun 13, 2022 $29.40 $29.40 $27.30 $27.90 30 667
Jun 10, 2022 $30.00 $30.90 $28.80 $30.00 32 270
Click to get the best stock tips daily for free!

About VistaGen Therapeutics Inc

VistaGen Therapeutics VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III development for the acute treatment of anxiety in adults with social anxiety disorder. Its PH94B product... VTGN Profile

Golden Star

Ticker Date Change Price
HRB Apr 29 1.00% $47.23
LYG Apr 29 0.391% $2.56
ORA Apr 29 1.95% $64.48
ETSY Apr 26 3.43% $67.43
DHT Apr 24 0.98% $11.28
LPLA Apr 19 1.10% $262.59
MLI Apr 19 7.29% $52.28
PFLT Apr 18 1.33% $11.25
DOOR Apr 18 0.94% $131.39
OCSL Apr 17 0.360% $19.43
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT